Loading…
The epidemiology of hepatitis B virus infection in Korea
The global burden of hepatitis B virus (HBV) infection is profound, and represents a public health threat as chronic infection can lead to liver cirrhosis, hepatocellular carcinoma, and death. The risk factors for chronic hepatitis B-related liver disease differ according to HBV endemicity, hepatiti...
Saved in:
Published in: | The Korean journal of internal medicine 2019, 34(5), , pp.945-953 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c487t-928d98c276ba21c6067d0969e13a47fade08494f5c6f97c0feac460cf8c2bca93 |
---|---|
cites | cdi_FETCH-LOGICAL-c487t-928d98c276ba21c6067d0969e13a47fade08494f5c6f97c0feac460cf8c2bca93 |
container_end_page | 953 |
container_issue | 5 |
container_start_page | 945 |
container_title | The Korean journal of internal medicine |
container_volume | 34 |
creator | Yim, Sun Young Kim, Ji Hoon |
description | The global burden of hepatitis B virus (HBV) infection is profound, and represents a public health threat as chronic infection can lead to liver cirrhosis, hepatocellular carcinoma, and death. The risk factors for chronic hepatitis B-related liver disease differ according to HBV endemicity, hepatitis B e-antigen seropositivity, and viral load. It is important to identify these risk factors and start antiviral treatment at an appropriate time according to current guidelines. The most crucial step in reducing HBV infection is prevention in infancy or early childhood, as infection at an early stage may lead to chronicity. South Korea was formerly an HBV-endemic area, but the epidemiology of HBV infection was changed by the introduction of vaccination in 1983 and nationwide immunization in 1995. The government and the private sector made efforts to reduce the prevalence of HBV infection, and Korea is on target to meet the World Health Organization goal of eliminating viral hepatitis by 2030. To eliminate hepatitis worldwide, the costs of antiviral treatment to prevent perinatal HBV transmission in pregnant women with high viremia should be covered by a national program, and strategies to reduce the prevalence of HBV infection in immigrant populations are needed. |
doi_str_mv | 10.3904/kjim.2019.007 |
format | article |
fullrecord | <record><control><sourceid>proquest_nrf_k</sourceid><recordid>TN_cdi_nrf_kci_oai_kci_go_kr_ARTI_5976352</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_fbb3df2411334b0881e04f92874ebd89</doaj_id><sourcerecordid>2199194304</sourcerecordid><originalsourceid>FETCH-LOGICAL-c487t-928d98c276ba21c6067d0969e13a47fade08494f5c6f97c0feac460cf8c2bca93</originalsourceid><addsrcrecordid>eNpVkU1vEzEURS0EoqGwZItmCYsJzx_x2BukUgGNqISEwtryeJ4TJzPjYE8q9d_jJKVqV7bs-8670iHkPYU51yA-77ZhmDOgeg7QvCAzBrCopRTqJZlRxmTNOfAL8ibnLYBsQPHX5IKDplqCmhG12mCF-9DhEGIf1_dV9NUG93YKU8jV1-oupEOuwujRTSGO5Vb9jAntW_LK2z7ju4fzkvz5_m11fVPf_vqxvL66rZ1QzVRrpjqtHGtkaxl1slToQEuNlFvReNshKKGFXzjpdePAo3VCgvNlpnVW80vy6cwdkzc7F0y04XSuo9klc_V7tTQL3Ui-YCW7PGe7aLdmn8Jg0_1p4PQQ09rYNAXXo_FtyzvPBKWcixaUogjCl7aNwLZTx71fzqz9oR2wczhOyfbPoM9_xrApne6MbGiBNAXw8QGQ4t8D5skMITvseztiPGTDqC4SBAdRovU56lLMOaF_XEPBHC2bo2VztGyK5ZL_8LTbY_q_Vv4Pj7OiqA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2199194304</pqid></control><display><type>article</type><title>The epidemiology of hepatitis B virus infection in Korea</title><source>PubMed Central (Open Access)</source><creator>Yim, Sun Young ; Kim, Ji Hoon</creator><creatorcontrib>Yim, Sun Young ; Kim, Ji Hoon</creatorcontrib><description>The global burden of hepatitis B virus (HBV) infection is profound, and represents a public health threat as chronic infection can lead to liver cirrhosis, hepatocellular carcinoma, and death. The risk factors for chronic hepatitis B-related liver disease differ according to HBV endemicity, hepatitis B e-antigen seropositivity, and viral load. It is important to identify these risk factors and start antiviral treatment at an appropriate time according to current guidelines. The most crucial step in reducing HBV infection is prevention in infancy or early childhood, as infection at an early stage may lead to chronicity. South Korea was formerly an HBV-endemic area, but the epidemiology of HBV infection was changed by the introduction of vaccination in 1983 and nationwide immunization in 1995. The government and the private sector made efforts to reduce the prevalence of HBV infection, and Korea is on target to meet the World Health Organization goal of eliminating viral hepatitis by 2030. To eliminate hepatitis worldwide, the costs of antiviral treatment to prevent perinatal HBV transmission in pregnant women with high viremia should be covered by a national program, and strategies to reduce the prevalence of HBV infection in immigrant populations are needed.</description><identifier>ISSN: 1226-3303</identifier><identifier>EISSN: 2005-6648</identifier><identifier>DOI: 10.3904/kjim.2019.007</identifier><identifier>PMID: 30919608</identifier><language>eng</language><publisher>Korea (South): The Korean Association of Internal Medicine</publisher><subject>Adolescent ; Adult ; Aged ; Antiviral Agents - therapeutic use ; Child ; Emigration and Immigration ; epidemiology ; Female ; Hepatitis B Vaccines - therapeutic use ; hepatitis b, chronic ; Hepatitis B, Chronic - epidemiology ; Hepatitis B, Chronic - prevention & control ; Hepatitis B, Chronic - transmission ; Humans ; Incidence ; Infectious Disease Transmission, Vertical ; Male ; Middle Aged ; Pregnancy ; Prevalence ; Prognosis ; Republic of Korea - epidemiology ; Review ; Risk Factors ; Time Factors ; vaccination ; Young Adult ; 내과학</subject><ispartof>The Korean Journal of Internal Medicine, 2019, 34(5), , pp.945-953</ispartof><rights>Copyright © 2019 The Korean Association of Internal Medicine 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c487t-928d98c276ba21c6067d0969e13a47fade08494f5c6f97c0feac460cf8c2bca93</citedby><cites>FETCH-LOGICAL-c487t-928d98c276ba21c6067d0969e13a47fade08494f5c6f97c0feac460cf8c2bca93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718747/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718747/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30919608$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002494298$$DAccess content in National Research Foundation of Korea (NRF)$$Hfree_for_read</backlink></links><search><creatorcontrib>Yim, Sun Young</creatorcontrib><creatorcontrib>Kim, Ji Hoon</creatorcontrib><title>The epidemiology of hepatitis B virus infection in Korea</title><title>The Korean journal of internal medicine</title><addtitle>Korean J Intern Med</addtitle><description>The global burden of hepatitis B virus (HBV) infection is profound, and represents a public health threat as chronic infection can lead to liver cirrhosis, hepatocellular carcinoma, and death. The risk factors for chronic hepatitis B-related liver disease differ according to HBV endemicity, hepatitis B e-antigen seropositivity, and viral load. It is important to identify these risk factors and start antiviral treatment at an appropriate time according to current guidelines. The most crucial step in reducing HBV infection is prevention in infancy or early childhood, as infection at an early stage may lead to chronicity. South Korea was formerly an HBV-endemic area, but the epidemiology of HBV infection was changed by the introduction of vaccination in 1983 and nationwide immunization in 1995. The government and the private sector made efforts to reduce the prevalence of HBV infection, and Korea is on target to meet the World Health Organization goal of eliminating viral hepatitis by 2030. To eliminate hepatitis worldwide, the costs of antiviral treatment to prevent perinatal HBV transmission in pregnant women with high viremia should be covered by a national program, and strategies to reduce the prevalence of HBV infection in immigrant populations are needed.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Antiviral Agents - therapeutic use</subject><subject>Child</subject><subject>Emigration and Immigration</subject><subject>epidemiology</subject><subject>Female</subject><subject>Hepatitis B Vaccines - therapeutic use</subject><subject>hepatitis b, chronic</subject><subject>Hepatitis B, Chronic - epidemiology</subject><subject>Hepatitis B, Chronic - prevention & control</subject><subject>Hepatitis B, Chronic - transmission</subject><subject>Humans</subject><subject>Incidence</subject><subject>Infectious Disease Transmission, Vertical</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Pregnancy</subject><subject>Prevalence</subject><subject>Prognosis</subject><subject>Republic of Korea - epidemiology</subject><subject>Review</subject><subject>Risk Factors</subject><subject>Time Factors</subject><subject>vaccination</subject><subject>Young Adult</subject><subject>내과학</subject><issn>1226-3303</issn><issn>2005-6648</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkU1vEzEURS0EoqGwZItmCYsJzx_x2BukUgGNqISEwtryeJ4TJzPjYE8q9d_jJKVqV7bs-8670iHkPYU51yA-77ZhmDOgeg7QvCAzBrCopRTqJZlRxmTNOfAL8ibnLYBsQPHX5IKDplqCmhG12mCF-9DhEGIf1_dV9NUG93YKU8jV1-oupEOuwujRTSGO5Vb9jAntW_LK2z7ju4fzkvz5_m11fVPf_vqxvL66rZ1QzVRrpjqtHGtkaxl1slToQEuNlFvReNshKKGFXzjpdePAo3VCgvNlpnVW80vy6cwdkzc7F0y04XSuo9klc_V7tTQL3Ui-YCW7PGe7aLdmn8Jg0_1p4PQQ09rYNAXXo_FtyzvPBKWcixaUogjCl7aNwLZTx71fzqz9oR2wczhOyfbPoM9_xrApne6MbGiBNAXw8QGQ4t8D5skMITvseztiPGTDqC4SBAdRovU56lLMOaF_XEPBHC2bo2VztGyK5ZL_8LTbY_q_Vv4Pj7OiqA</recordid><startdate>20190901</startdate><enddate>20190901</enddate><creator>Yim, Sun Young</creator><creator>Kim, Ji Hoon</creator><general>The Korean Association of Internal Medicine</general><general>대한내과학회</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><scope>ACYCR</scope></search><sort><creationdate>20190901</creationdate><title>The epidemiology of hepatitis B virus infection in Korea</title><author>Yim, Sun Young ; Kim, Ji Hoon</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c487t-928d98c276ba21c6067d0969e13a47fade08494f5c6f97c0feac460cf8c2bca93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Antiviral Agents - therapeutic use</topic><topic>Child</topic><topic>Emigration and Immigration</topic><topic>epidemiology</topic><topic>Female</topic><topic>Hepatitis B Vaccines - therapeutic use</topic><topic>hepatitis b, chronic</topic><topic>Hepatitis B, Chronic - epidemiology</topic><topic>Hepatitis B, Chronic - prevention & control</topic><topic>Hepatitis B, Chronic - transmission</topic><topic>Humans</topic><topic>Incidence</topic><topic>Infectious Disease Transmission, Vertical</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Pregnancy</topic><topic>Prevalence</topic><topic>Prognosis</topic><topic>Republic of Korea - epidemiology</topic><topic>Review</topic><topic>Risk Factors</topic><topic>Time Factors</topic><topic>vaccination</topic><topic>Young Adult</topic><topic>내과학</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yim, Sun Young</creatorcontrib><creatorcontrib>Kim, Ji Hoon</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals (Open Access)</collection><collection>Korean Citation Index</collection><jtitle>The Korean journal of internal medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yim, Sun Young</au><au>Kim, Ji Hoon</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The epidemiology of hepatitis B virus infection in Korea</atitle><jtitle>The Korean journal of internal medicine</jtitle><addtitle>Korean J Intern Med</addtitle><date>2019-09-01</date><risdate>2019</risdate><volume>34</volume><issue>5</issue><spage>945</spage><epage>953</epage><pages>945-953</pages><issn>1226-3303</issn><eissn>2005-6648</eissn><abstract>The global burden of hepatitis B virus (HBV) infection is profound, and represents a public health threat as chronic infection can lead to liver cirrhosis, hepatocellular carcinoma, and death. The risk factors for chronic hepatitis B-related liver disease differ according to HBV endemicity, hepatitis B e-antigen seropositivity, and viral load. It is important to identify these risk factors and start antiviral treatment at an appropriate time according to current guidelines. The most crucial step in reducing HBV infection is prevention in infancy or early childhood, as infection at an early stage may lead to chronicity. South Korea was formerly an HBV-endemic area, but the epidemiology of HBV infection was changed by the introduction of vaccination in 1983 and nationwide immunization in 1995. The government and the private sector made efforts to reduce the prevalence of HBV infection, and Korea is on target to meet the World Health Organization goal of eliminating viral hepatitis by 2030. To eliminate hepatitis worldwide, the costs of antiviral treatment to prevent perinatal HBV transmission in pregnant women with high viremia should be covered by a national program, and strategies to reduce the prevalence of HBV infection in immigrant populations are needed.</abstract><cop>Korea (South)</cop><pub>The Korean Association of Internal Medicine</pub><pmid>30919608</pmid><doi>10.3904/kjim.2019.007</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1226-3303 |
ispartof | The Korean Journal of Internal Medicine, 2019, 34(5), , pp.945-953 |
issn | 1226-3303 2005-6648 |
language | eng |
recordid | cdi_nrf_kci_oai_kci_go_kr_ARTI_5976352 |
source | PubMed Central (Open Access) |
subjects | Adolescent Adult Aged Antiviral Agents - therapeutic use Child Emigration and Immigration epidemiology Female Hepatitis B Vaccines - therapeutic use hepatitis b, chronic Hepatitis B, Chronic - epidemiology Hepatitis B, Chronic - prevention & control Hepatitis B, Chronic - transmission Humans Incidence Infectious Disease Transmission, Vertical Male Middle Aged Pregnancy Prevalence Prognosis Republic of Korea - epidemiology Review Risk Factors Time Factors vaccination Young Adult 내과학 |
title | The epidemiology of hepatitis B virus infection in Korea |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T01%3A35%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_nrf_k&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20epidemiology%20of%20hepatitis%20B%20virus%20infection%20in%20Korea&rft.jtitle=The%20Korean%20journal%20of%20internal%20medicine&rft.au=Yim,%20Sun%20Young&rft.date=2019-09-01&rft.volume=34&rft.issue=5&rft.spage=945&rft.epage=953&rft.pages=945-953&rft.issn=1226-3303&rft.eissn=2005-6648&rft_id=info:doi/10.3904/kjim.2019.007&rft_dat=%3Cproquest_nrf_k%3E2199194304%3C/proquest_nrf_k%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c487t-928d98c276ba21c6067d0969e13a47fade08494f5c6f97c0feac460cf8c2bca93%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2199194304&rft_id=info:pmid/30919608&rfr_iscdi=true |